Inito

United States - San Francisco, California

• 16/11/2023
• Series A
• $6,000,000

Inito is on a mission to simplify healthcare and wellness with the most advanced health trackers. Our devices are engineered to help you take complete control of your well-being by accessing real-time data and values at your fingertips.

Inito has recorded 8X growth in 2022, is projected to grow over 4X in 2023 and launch in 10+ countries through 2024.

The Inito Fertility Monitor is the only hormone tracking device that accurately measures all four fertility hormones. It is trusted by over 20,000+ couples in India & US.

Inito is backed by the best investors in the world – Y Combinator and many others in US, Singapore & India.

Related People

Aayush RaiCo Founder

India - Bengaluru, Karnataka

Growing up, I dreamt of flying cars & health tricorders available in every home. Only to find the smartest of my peers spending life figuring out how to deliver packages faster.

We started Inito to solve the hard problems of humanity - like giving people control of their health.

Inito is the world’s first comprehensive at-home diagnostics device that allows diagnostic tests for fertility, diabetes, vitamins, thyroid and dozens more on a single device connected to a smartphone.

By collecting data about your body, our App provides personalized insights, treatments and lifestyle modifications to help millions of people become healthier and get back to living the lives they dream about.

Inito is backed by the best investors in the world – Y Combinator and many others in US, Singapore & India.

LinkedIn https://www.linkedin.com/in/aayushinito/